How to buy NovaBay Pharmaceuticals stock (NBY)

NovaBay Pharmaceuticals is a biotechnology business based in the US. NovaBay Pharmaceuticals shares (NBY) are listed on the NYSE MKT and all prices are listed in US Dollars. Its last market close was $0.53 – a decrease of 7.83% over the previous week. NovaBay Pharmaceuticals employs 24 staff and has a trailing 12-month revenue of around $13.1 million.

Our top picks for where to buy NovaBay Pharmaceuticals stock

Buy NovaBay Pharmaceuticals stock from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.

Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.

Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.

NovaBay Pharmaceuticals stock price (NYSE MKT: NBY)

Use our graph to track the performance of NBY stocks over time.

NovaBay Pharmaceuticals shares at a glance

• Key figures

Information last updated 2024-12-19.

Latest market close	$0.53
52-week range	$0.36 - $8.36
50-day moving average more info button	$0.64
200-day moving average more info button	$1.92
Wall St. target price	$3.73
PE ratio more info button	N/A
Dividend yield more info button	N/A
Earnings per share (TTM) more info button	$-74.61

Is it a good time to buy NovaBay Pharmaceuticals stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

NovaBay Pharmaceuticals price performance over time

Historical closes compared with the close of $0.5041 from 2024-12-19

1 week (2024-12-13)	-12.32%
1 month (2024-11-22)	-25.98%
3 months (2024-09-20)	-31.88%
6 months (2024-06-21)	-76.44%

1 year (2023-12-22)	124.04%
2 years (2022-12-22)	-99.03%
3 years (2021-12-21)	549.1675
5 years (2019-12-20)	738.5525

NovaBay Pharmaceuticals financials

Revenue TTM	$13.1 million
Gross profit TTM	$5.6 million
Return on assets TTM	-38.67%
Return on equity TTM	-263.83%
Profit margin	-77.48%
Book value	$0.22
Market Capitalization more info button	$2.4 million

TTM: trailing 12 months

NovaBay Pharmaceuticals share dividends

We're not expecting NovaBay Pharmaceuticals to pay a dividend over the next 12 months.

Have NovaBay Pharmaceuticals's shares ever split?

NovaBay Pharmaceuticals's shares were split on a 1:35 basis on 30 May 2024 . So if you had owned 35 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your NovaBay Pharmaceuticals shares – just the quantity. However, indirectly, the new 3400% higher share price could have impacted the market appetite for NovaBay Pharmaceuticals shares which in turn could have impacted NovaBay Pharmaceuticals's share price.

NovaBay Pharmaceuticals share price volatility

Over the last 12 months, NovaBay Pharmaceuticals's shares have ranged in value from as little as $0.3611 up to $8.358. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NYSE MKT average) beta is 1, while NovaBay Pharmaceuticals's is 0.732. This would suggest that NovaBay Pharmaceuticals's shares are less volatile than average (for this exchange).

NovaBay Pharmaceuticals overview

NovaBay Pharmaceuticals, Inc. develops and sells eyecare and wound care products in the United States and internationally. It offers Avenova Spray, a solution for removing foreign materials, including microorganisms and debris from skin around the eye, such as the eyelid; Avenova Eye Health Support antioxidant-rich oral supplements; Avenova Lubricating Eye Drops for instant relief; NovaWipes by Avenova; Avenova WarmEye Compress to soothe the eyes; and the i-Chek by Avenova to monitor physical eyelid health. The company also provides wound care products, which are used for cleansing and irrigation as part of surgical procedures, as well as treating wounds, burns, ulcers, and other injuries under the NeutroPhase and PhaseOne brands. It sells its products through the company's web stores, third-party online retailers and distribution partners. The company was formerly known as NovaCal Pharmaceuticals, Inc. and changed its name to NovaBay Pharmaceuticals, Inc.

Frequently asked questions

What percentage of NovaBay Pharmaceuticals is owned by insiders or institutions?
Currently 0.024% of NovaBay Pharmaceuticals shares are held by insiders and 2.578% by institutions. How many people work for NovaBay Pharmaceuticals?
Latest data suggests 24 work at NovaBay Pharmaceuticals. When does the fiscal year end for NovaBay Pharmaceuticals?
NovaBay Pharmaceuticals's fiscal year ends in December. Where is NovaBay Pharmaceuticals based?
NovaBay Pharmaceuticals's address is: 2000 Powell Street, Emeryville, CA, United States, 94608 What is NovaBay Pharmaceuticals's ISIN number?
NovaBay Pharmaceuticals's international securities identification number is: US66987P2011 What is NovaBay Pharmaceuticals's CUSIP number?
NovaBay Pharmaceuticals's Committee on Uniform Securities Identification Procedures number is: 66987P201